Tg Therapeutics reported $14.25M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.3B 174M
Amgen AMGN:US USD 1.29B 40M
Ardelyx ARDX:US USD 18.67M 195K
Arrowhead Research ARWR:US USD 31.62M 1.11M
Bayer BAYN:GR EUR 4.08B 393M
Biogen BIIB:US USD 563.3M 9.3M
Corcept Therapeutics CORT:US USD 35.16M 2.65M
Curis CRIS:US USD 9.11M 4.02M
Dynavax Technologies DVAX:US USD 32.04M 3.69M
Gilead Sciences GILD:US USD 1.21B 144M
Infinity Pharmaceuticals INFI:US USD 3.5M 6K
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
Johnson & Johnson JNJ:US USD 6.09B 137M
Karyopharm Therapeutics KPTI:US USD 34.64M 2.69M
Novartis NOVN:VX USD 3.4B 185M
Novavax NVAX:US USD 122.88M 14.72M
Ptc Therapeutics PTCT:US USD 80.12M 226K
Puma Biotechnology PBYI:US USD 23.96M 3.38M
Regeneron Pharmaceuticals REGN:US USD 529.1M 52.8M
Spectrum Pharmaceuticals SPPI:US USD 8.26M 1.12M
Tg Therapeutics TGTX:US USD 14.25M 1.62M
Verastem VSTM:US USD 6.42M 93K
Vertex Pharmaceuticals VRTX:US USD 246.8M 31.5M
Ziopharm Oncology ZIOP:US USD 3.28M 147K